{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:42:22Z","timestamp":1780605742980,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"DOI":"10.7759\/cureus.86457","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T01:06:45Z","timestamp":1750468005000},"source":"Crossref","is-referenced-by-count":1,"title":["Dasatinib-Induced Polymyositis-Like Syndrome: A Report of a Rare Case"],"prefix":"10.7759","author":[{"given":"Arathi","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana","family":"Keshavamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamim","family":"Sultani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Shastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-4-322","article-title":"Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment","volume":"17","author":"Oldroyd A","year":"2017","unstructured":"Oldroyd A, Lilleker J, Chinoy H. Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment. Clin Med (Lond). 2017, 17:322-8. 10.7861\/clinmedicine.17-4-322","journal-title":"Clin Med (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2022.06.007","article-title":"Environmental risks for inflammatory myopathies","volume":"48","author":"Che WI","year":"2022","unstructured":"Che WI, Lundberg IE, Holmqvist M. Environmental risks for inflammatory myopathies. Rheum Dis Clin North Am. 2022, 48:861-74. 10.1016\/j.rdc.2022.06.007","journal-title":"Rheum Dis Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg IE","year":"2016","unstructured":"Lundberg IE, Miller FW, Tj\u00e4rnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016, 280:39-51. 10.1111\/joim.12524","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084301","article-title":"Pathophysiological mechanisms and treatment of dermatomyositis and immune mediated necrotizing myopathies: a focused review","volume":"23","author":"Kamperman RG","year":"2022","unstructured":"Kamperman RG, van der Kooi AJ, de Visser M, Aronica E, Raaphorst J. Pathophysiological mechanisms and treatment of dermatomyositis and immune mediated necrotizing myopathies: a focused review. Int J Mol Sci. 2022, 23:4212. 10.3390\/ijms23084301","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.11.005","article-title":"Statins as a possible cause of inflammatory and necrotizing myopathies","volume":"222","author":"Padala S","year":"2012","unstructured":"Padala S, Thompson PD. Statins as a possible cause of inflammatory and necrotizing myopathies. Atherosclerosis. 2012, 222:15-21. 10.1016\/j.atherosclerosis.2011.11.005","journal-title":"Atherosclerosis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas MC","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015, 372:1734-47. 10.1056\/NEJMra1402225","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0677-x","article-title":"Dasatinib: a review in chronic myeloid leukaemia and Ph+ acute lymphoblastic leukaemia","volume":"77","author":"Keating GM","year":"2017","unstructured":"Keating GM. Dasatinib: a review in chronic myeloid leukaemia and Ph+ acute lymphoblastic leukaemia. Drugs. 2017, 77:85-96. 10.1007\/s40265-016-0677-x","journal-title":"Drugs"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1113462","article-title":"Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: characteristics, potential mechanisms, and clinical management strategies","volume":"13","author":"Cheng F","year":"2023","unstructured":"Cheng F, Xu Q, Li Q, Cui Z, Li W, Zeng F. Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: characteristics, potential mechanisms, and clinical management strategies. Front Oncol. 2023, 13:1113462. 10.3389\/fonc.2023.1113462","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.12l01451","article-title":"A case of cocaine-induced myopathy","volume":"15","author":"Selvaraj V","year":"2013","unstructured":"Selvaraj V, Gollamudi LR, Sharma A, Madabushi J. A case of cocaine-induced myopathy. Prim Care Companion CNS Disord. 2013, 15:10.4088\/PCC.12l01451","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-001-0422-7","article-title":"Philadelphia-positive T-cell acute lymphoblastic leukemia with polymyositis, migratory polyarthritis and hypercalcemia following a chronic myeloid leukemia","volume":"81","author":"Lima M","year":"2002","unstructured":"Lima M, Coutinho J, Bernardo L, et al.. Philadelphia-positive T-cell acute lymphoblastic leukemia with polymyositis, migratory polyarthritis and hypercalcemia following a chronic myeloid leukemia. Ann Hematol. 2002, 81:174-7. 10.1007\/s00277-001-0422-7","journal-title":"Ann Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-2984-4","article-title":"Dermatomyositis as a complication of interferon-\u03b1 therapy: a case report and review of the literature","volume":"34","author":"Shiba H","year":"2014","unstructured":"Shiba H, Takeuchi T, Isoda K, Kokunai Y, Wada Y, Makino S, Hanafusa T. Dermatomyositis as a complication of interferon-\u03b1 therapy: a case report and review of the literature. Rheumatol Int. 2014, 34:1319-22. 10.1007\/s00296-014-2984-4","journal-title":"Rheumatol Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.74","article-title":"Hydroxyurea-induced dermatomyositis-like eruption","volume":"48","author":"Dacey MJ","year":"2003","unstructured":"Dacey MJ, Callen JP. Hydroxyurea-induced dermatomyositis-like eruption. J Am Acad Dermatol. 2003, 48:439-41. 10.1067\/mjd.2003.74","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116767","article-title":"Purulent infectious myositis (formerly tropical pyomyositis)","volume":"413","author":"Habeych ME","year":"2020","unstructured":"Habeych ME, Trinh T, Crum-Cianflone NF. Purulent infectious myositis (formerly tropical pyomyositis). J Neurol Sci. 2020, 413:116767. 10.1016\/j.jns.2020.116767","journal-title":"J Neurol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13395","article-title":"Tropical pyomyositis: an update","volume":"25","author":"Shittu A","year":"2020","unstructured":"Shittu A, Deinhardt-Emmer S, Vas Nunes J, Niemann S, Grobusch MP, Schaumburg F. Tropical pyomyositis: an update. Trop Med Int Health. 2020, 25:660-5. 10.1111\/tmi.13395","journal-title":"Trop Med Int Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2007.06.005","article-title":"Pyomyositis associated with hematological malignancy: case report and review of the literature","volume":"12","author":"Falagas ME","year":"2008","unstructured":"Falagas ME, Rafailidis PI, Kapaskelis A, Peppas G. Pyomyositis associated with hematological malignancy: case report and review of the literature. Int J Infect Dis. 2008, 12:120-5. 10.1016\/j.ijid.2007.06.005","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983216","article-title":"Pyomyositis as a focus of infection in hematological disorders: a report of 3 cases","volume":"77","author":"Hayashi T","year":"2003","unstructured":"Hayashi T, Nozaki M, Nonaka Y, Ohashi K, Sakamaki H, Nomura T. Pyomyositis as a focus of infection in hematological disorders: a report of 3 cases. Int J Hematol. 2003, 77:171-4. 10.1007\/BF02983216","journal-title":"Int J Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-015-0674-9","article-title":"Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case report","volume":"9","author":"AlJohani NI","year":"2015","unstructured":"AlJohani NI, Carette S, Lipton JH. Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case report. J Med Case Rep. 2015, 9:214. 10.1186\/s13256-015-0674-9","journal-title":"J Med Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1398453","article-title":"Imatinib-induced dermatomyositis sine dermatitis - a rare case report","volume":"15","author":"Silva A","year":"2024","unstructured":"Silva A, Rom\u00e3o VC, Campanilho-Marques R. Imatinib-induced dermatomyositis sine dermatitis - a rare case report. Front Immunol. 2024, 15:1398453. 10.3389\/fimmu.2024.1398453","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16117","article-title":"Disease spectrum of myopathies with elevated aldolase and normal creatine kinase","volume":"31","author":"Soontrapa P","year":"2024","unstructured":"Soontrapa P, Shahar S, Eauchai L, Ernste FC, Liewluck T. Disease spectrum of myopathies with elevated aldolase and normal creatine kinase. Eur J Neurol. 2024, 31:e16117. 10.1111\/ene.16117","journal-title":"Eur J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.05.008","article-title":"Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications","volume":"201","author":"Solouki S","year":"2019","unstructured":"Solouki S, August A, Huang W. Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications. Pharmacol Ther. 2019, 201:39-50. 10.1016\/j.pharmthera.2019.05.008","journal-title":"Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/373595-dasatinib-induced-polymyositis-like-syndrome-a-report-of-a-rare-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T01:06:46Z","timestamp":1750468006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/373595-dasatinib-induced-polymyositis-like-syndrome-a-report-of-a-rare-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.86457","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}